{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:28:12Z","timestamp":1790011692543,"version":"4.0.1"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T00:00:00Z","timestamp":1586649600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T00:00:00Z","timestamp":1586649600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100006436","name":"Celgene","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006436","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Dermatol Res"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s00403-020-02066-1","type":"journal-article","created":{"date-parts":[[2020,4,12]],"date-time":"2020-04-12T11:02:05Z","timestamp":1586689325000},"page":"89-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Gender differences in psoriasis: a Swiss online psoriasis survey"],"prefix":"10.1007","volume":"313","author":[{"given":"Carla","family":"Murer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Sgier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia Kyonhi","family":"Mettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Guillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia-Tatjana","family":"Maul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Djamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander A.","family":"Navarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Anzengruber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,12]]},"reference":[{"issue":"3","key":"2066_CR1","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1111\/j.1365-2133.2010.09831.x","volume":"163","author":"M Augustin","year":"2010","unstructured":"Augustin M, Reich K, Blome C, Schafer I, Laass A, Radtke MA (2010) Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol 163(3):580\u2013585","journal-title":"Br J Dermatol"},{"issue":"2","key":"2066_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2340\/00015555-0770","volume":"90","author":"M Augustin","year":"2010","unstructured":"Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M (2010) Co-morbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 90(2):147\u2013151","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"2066_CR3","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1590\/abd1806-4841.20175402","volume":"92","author":"AG Bahali","year":"2017","unstructured":"Bahali AG, Onsun N, Su O, Ozkaya DB, Dizman D, Topukcu B et al (2017) The relationship between pruritus and clinical variables in patients with psoriasis. An Bras Dermatol 92(4):470\u2013473","journal-title":"An Bras Dermatol"},{"issue":"1","key":"2066_CR4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1046\/j.1365-2133.1996.d01-935.x","volume":"135","author":"T Basarab","year":"1996","unstructured":"Basarab T, Munn SE, Jones RR (1996) Diagnostic accuracy and appropriateness of general practitioner referrals to a dermatology out-patient clinic. Br J Dermatol 135(1):70\u201373","journal-title":"Br J Dermatol"},{"issue":"10","key":"2066_CR5","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1007\/s00403-019-01945-6","volume":"311","author":"M Drach","year":"2019","unstructured":"Drach M, Papageorgiou K, Maul JT, Djamei V, Yawalkar N, Hausermann P et al (2019) Effectiveness of methotrexate in moderate to severe psoriasis patients: real-world registry data from the Swiss Dermatology Network for Targeted Therapies (SDNTT). Arch Dermatol Res 311(10):753\u2013760","journal-title":"Arch Dermatol Res"},{"issue":"8","key":"2066_CR6","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/jdv.15450","volume":"33","author":"B Elewski","year":"2019","unstructured":"Elewski B, Alexis AF, Lebwohl M, Stein Gold L, Pariser D, Del Rosso J et al (2019) Itch: an under-recognized problem in psoriasis. J Eur Acad Dermatol Venereol 33(8):1465\u20131476","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"5","key":"2066_CR7","doi-asserted-by":"publisher","first-page":"e63619","DOI":"10.1371\/journal.pone.0063619","volume":"8","author":"D Hagg","year":"2013","unstructured":"Hagg D, Eriksson M, Sundstrom A, Schmitt-Egenolf M (2013) The higher proportion of men with psoriasis treated with biologics may be explained by more severe disease in men. PLoS ONE 8(5):e63619","journal-title":"PLoS ONE"},{"issue":"4","key":"2066_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1067\/mjd.2000.101596","volume":"42","author":"RS Hotard","year":"2000","unstructured":"Hotard RS, Feldman SR, Fleischer AB Jr (2000) Sex-specific differences in the treatment of severe psoriasis. J Am Acad Dermatol 42(4):620\u2013623","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"2066_CR9","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jaad.2013.12.018","volume":"70","author":"MG Lebwohl","year":"2014","unstructured":"Lebwohl MG, Bachelez H, Barker J, Girolomoni G, Kavanaugh A, Langley RG et al (2014) Patient perspectives in the management of psoriasis: results from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis Survey. J Am Acad Dermatol. 70(5):871\u2013881e1-30","journal-title":"J Am Acad Dermatol."},{"issue":"4","key":"2066_CR10","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1111\/jdv.15324","volume":"33","author":"JT Maul","year":"2019","unstructured":"Maul JT, Navarini AA, Sommer R, Anzengruber F, Sorbe C, Mrowietz U et al (2019) Gender and age significantly determine patient needs and treatment goals in psoriasis\u2014a lesson for practice. J Eur Acad Dermatol Venereol 33(4):700\u2013708","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"2066_CR11","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/embor.2012.87","volume":"13","author":"V Regitz-Zagrosek","year":"2012","unstructured":"Regitz-Zagrosek V (2012) Sex and gender differences in health. Science & Society series on sex and science. EMBO Rep 13(7):596\u2013603","journal-title":"EMBO Rep"},{"issue":"21","key":"2066_CR12","first-page":"2095","volume":"376","author":"CT Ritchlin","year":"2017","unstructured":"Ritchlin CT, Colbert RA, Gladman DD (2017) Psoriatic Arthritis. N Engl J Med 376(21):2095\u20132096","journal-title":"N Engl J Med"},{"issue":"4","key":"2066_CR13","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.pec.2015.10.033","volume":"99","author":"TAM Teunissen","year":"2016","unstructured":"Teunissen TAM, Rotink ME, Lagro-Janssen ALM (2016) Gender differences in quality of care experiences during hospital stay: a contribution to patient-centered healthcare for both men and women. Patient Educ Couns 99(4):631\u2013637","journal-title":"Patient Educ Couns"},{"issue":"10","key":"2066_CR14","doi-asserted-by":"publisher","first-page":"1913","DOI":"10.1111\/jdv.15733","volume":"33","author":"LS van der Schoot","year":"2019","unstructured":"van der Schoot LS, van den Reek J, Groenewoud JMM, Otero ME, Njoo MD, Ossenkoppele PM et al (2019) Female patients are less satisfied with biological treatment for psoriasis and experience more side-effects than male patients: results from the prospective BioCAPTURE registry. J Eur Acad Dermatol Venereol 33(10):1913\u20131920","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Archives of Dermatological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00403-020-02066-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00403-020-02066-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,11]],"date-time":"2021-04-11T23:05:41Z","timestamp":1618182341000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00403-020-02066-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,12]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2066"],"URL":"https:\/\/doi.org\/10.1007\/s00403-020-02066-1","relation":{},"ISSN":["0340-3696","1432-069X"],"issn-type":[{"value":"0340-3696","type":"print"},{"value":"1432-069X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,12]]},"assertion":[{"value":"19 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"C.M. reports no conflict of interest. D.S. is a former employee of Celgene Inc., but has no conflict of interest. S.M has no conflict of interest. C.G has no conflicts of interest. J-T. M. is an employee of USZ and received a \u201cfilling the GAP\u201d stipend. V.D. has honoraria from AbbVie, Celgene, Eli Lilly, Leo Pharma, Novartis and Sanofi. A. A. N was funded by the Promedica and Bruno-Bloch Foundation, as well as Hochspezialisierte Medizin 2 of the Kanton Z\u00fcrich, Switzerland. He is also on the advisory board of AbbVie, Pfizer, Novartis, Celgene, MSD and Galderma and has received grants from AbbVie, Novartis, Celgene and others. F.A. has received honoraria from Abbvie, Celgene, Leo Pharma, Galderma, Eli Lilly, Janssen-Cilag, Novartis, Galderma and Almirall, but has no financial interest, nor holds any shares of any pharmaceutical company.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}